WhistlePig Whiskey, through bold experimentation in blending and finishing, is changing how the rye whiskey category is perceived.
We all have a concept of reality. We know what is “fact” and what isn’t. However, the truth of the matter is that the definition of “real” is a mere construct of the brain. If that didn’t blow your ...
There is so much information about the world and life itself out there that it’s almost unfathomable. And every now and then, you will learn new information that will blow your mind into a thousand ...
The best part about chaos is that studying chaos in nature quiets our inner chaos. That is, our nervous systems appear wired ...
As India’s first AI company to IPO, Fractal Analytics didn’t have a stellar first day on the public markets, as enthusiasm for the technology collided with jittery investors recovering from a major ...
Fractal Analytics Share Price, IPO GMP, Listing Live Updates: The allotment of the shares was finalised on Feb 13 (Image: Canva) Fractal Analytics Share Price, IPO Listing, GMP Highlights: Fractal ...
It’s not easy to distinguish one wireless headset from another in such a crowded current marketplace in the $150-$200 bracket, but case specialist Fractal has shown a typically considered approach to ...
Fractal Analytics IPO listing: The shares of Fractal Analytics will make their stock market debut on Monday, February 16, after the mainboard IPO received a moderate response from investors during the ...
Fractal Analytics shares rose nearly 6% on February 17 after Prabhudas Lilladhar (PL) recommended a 'Buy' with a target price of ₹1,260, indicating a 40% upside.(Pixabay) Fractal Analytics share price ...
Fractal Analytics IPO allotment likely to be finalised on February 12. Fractal Analytics IPO allotment to be finalized tonight after 2.66x subscription. Shares to list on NSE and BSE on February 16.
Fractal Analytics shares listed at a 2.67 percent discount on NSE. IPO was subscribed 2.66 times; market cap at Rs 15,476.86 crore. Proceeds to fund US subsidiary, R&D, and strategic initiatives. Did ...
Endothelial cells in tumor blood vessels respond to angiogenic factors by upregulating their rates of proliferation, migration and differentiation and lowering their rate of apoptosis, but these ...